India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
iOS 26.0.1 update for iPhone, Bluetooth and Wi-Fi problem solved Apple has released the iOS 26.0.1 update for its users. Although this update, which came on Monday, is not a major update, the company has presented it as an important version that fixes the errors seen in the previous version. According to Apple, the new update will resolve the Bluetooth and Wi-Fi ‘disconnection’ issues that appeared in iOS 26 . These problems were especially seen in the iPhone 17 series . Along with this, the company claims that the cellular network problem experienced by some users will also be resolved. iOS 26.0.1 and iPadOS 26.0.1 will fix connectivity errors seen in the iPhone 17 , iPhone Air and iPhone 17 Pro models . This version is expected to be useful for users who have complained of network stability problems after updating the previous version. The new update is available from iPhone 11 to later models. Users in Nepal will also be able to download and use the iOS 26.0.1 update.